CN104172159A - Composition with auxiliary protection effect on alcoholic liver injury and preparation method thereof - Google Patents
Composition with auxiliary protection effect on alcoholic liver injury and preparation method thereof Download PDFInfo
- Publication number
- CN104172159A CN104172159A CN201410356846.9A CN201410356846A CN104172159A CN 104172159 A CN104172159 A CN 104172159A CN 201410356846 A CN201410356846 A CN 201410356846A CN 104172159 A CN104172159 A CN 104172159A
- Authority
- CN
- China
- Prior art keywords
- composition
- parts
- extract
- liver
- liver injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 231100000753 hepatic injury Toxicity 0.000 title claims abstract description 46
- 206010067125 Liver injury Diseases 0.000 title claims abstract description 40
- 230000001476 alcoholic effect Effects 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 230000000694 effects Effects 0.000 title abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 63
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 38
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 38
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 240000006365 Vitis vinifera Species 0.000 claims description 28
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 28
- 244000163122 Curcuma domestica Species 0.000 claims description 18
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 18
- 235000003373 curcuma longa Nutrition 0.000 claims description 18
- 235000013976 turmeric Nutrition 0.000 claims description 18
- 235000017276 Salvia Nutrition 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 235000013402 health food Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 235000013376 functional food Nutrition 0.000 claims description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 3
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 2
- 241001072909 Salvia Species 0.000 claims 6
- 238000007873 sieving Methods 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 35
- 230000006870 function Effects 0.000 abstract description 18
- 230000001681 protective effect Effects 0.000 abstract description 8
- 210000000582 semen Anatomy 0.000 abstract description 7
- 230000003859 lipid peroxidation Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 4
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 238000011990 functional testing Methods 0.000 abstract 1
- 238000005502 peroxidation Methods 0.000 abstract 1
- 229940052016 turmeric extract Drugs 0.000 abstract 1
- 235000020240 turmeric extract Nutrition 0.000 abstract 1
- 239000008513 turmeric extract Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- 238000012360 testing method Methods 0.000 description 26
- 240000007164 Salvia officinalis Species 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000002440 hepatic effect Effects 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 235000005412 red sage Nutrition 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000005229 liver cell Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000012754 curcumin Nutrition 0.000 description 5
- 229940109262 curcumin Drugs 0.000 description 5
- 239000004148 curcumin Substances 0.000 description 5
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 208000007848 Alcoholism Diseases 0.000 description 4
- 244000202052 Poncirus trifoliata Species 0.000 description 4
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- 201000007930 alcohol dependence Diseases 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 201000011452 Adrenoleukodystrophy Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 3
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- 208000010796 X-linked adrenoleukodystrophy Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- -1 flavone compound Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 239000001685 glycyrrhizic acid Substances 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000003617 peroxidasic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000005180 public health Effects 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000002110 toxicologic effect Effects 0.000 description 3
- 231100000027 toxicology Toxicity 0.000 description 3
- HYXITZLLTYIPOF-UHFFFAOYSA-N 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 description 2
- 108010001202 Cytochrome P-450 CYP2E1 Proteins 0.000 description 2
- 102100024889 Cytochrome P450 2E1 Human genes 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 102000002737 Heme Oxygenase-1 Human genes 0.000 description 2
- 108010018924 Heme Oxygenase-1 Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000008235 industrial water Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000011122 softwood Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 101000672034 Bacillus sp. (strain GL1) Unsaturated glucuronyl hydrolase Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- RMMPZDDLWLALLJ-UHFFFAOYSA-N Thermophillin Chemical compound COC1=CC(=O)C(OC)=CC1=O RMMPZDDLWLALLJ-UHFFFAOYSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 210000004024 hepatic stellate cell Anatomy 0.000 description 1
- 231100000437 hepatocellular injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical group 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a composition with an auxiliary protection effect on an alcoholic liver injury and a preparation method of the composition. The composition with the auxiliary protective effect on the alcoholic liver injury is mainly prepared from the following raw materials in parts by weight: 57.5-172.5 parts of kudzuvine root extract, 22.5-67.5 parts of semen hoveniae extract, 35-105 parts of salvia miltiorrhiza extract, 18-57 parts of turmeric extract and 7.5-22.5 parts of ammonium glycyrrhetate. The raw materials respectively have anti-lipid peroxidation effect and protective effect on the liver. Functional tests show that the composition with the auxiliary protection effect on the alcoholic liver injury has better liver protection effect compared with the same dose of single kudzuvine root extract preparation and single semen hoveniae extract preparation, and liver fatty degeneration and liver lipid peroxidation which are caused by the alcoholic liver injury can be obviously alleviated. The composition with the auxiliary protection effect is prepared by adopting a scientific and reasonable production process, is definite in functions, controllable in quality and safe to take and is applicable to a large group of people suffering from the alcoholic liver injury.
Description
Technical field
The present invention relates to a kind of composition and method of making the same that alcoholic liver injury is had to auxiliary protection function, belong to health food technology field.
Background technology
Alcoholic liver injury (alcoholic liver disease, ALD) is the Poisoning liver diseases causing because of long-term excessive consumption of alcohol, and ALDShi western countries patient causes the main reason of cirrhosis.At China's AML, there is in recent years the trend increasing gradually, become the second largest hepatopathy cause of disease that is only second to virus hepatitis at present.
AML is due to the liver diseases due to long-term heavy drinking, initial stage is usually expressed as fatty liver, and then can develop into alcoholic hepatitis, alcoholic fibrosis and alcoholic cirrhosis, even while seriously indulging in excessive drinking, can bring out extensive necrosis of liver cells liver failure.So far also there is no clinically effectively to prevent and treat the ideal medicament that development occurs liver diseases.Think at present, alcohol has the hepatocellular toxic action of direct infringement, is the fundamental cause that causes hepatic lesion, and oxidative stress and lipid peroxidation are that alcohol causes one of key factor of hepar damnification.80~the 150g that drinks general every day, can cause hepatic injury in continuous 5 years; Heavy drinking is more than 20 years, and 40%~50% cirrhosis can occur.
The pathogenesis of ALD is not fully aware of at present, and the lipid peroxidation of free radical and mediation thereof is considered to topmost paathogenic factor.Ethanol can produce a large amount of free radicals: O when liver metabolism
2 -, H
2o
2, OH
-, C
2h
5o
-and C
2h
5oH
-, excessive free radical can cause liver plasma membrane generation peroxidatic reaction of lipid, makes cell membrane and organelle structural deterioration, membrane fluidity is not normal; A large amount of liver cell endoenzymes (ALT, AST) are released into blood, and can make to remove free radical enzyme (SOD, GPx) and exhaust, hepatocellular injury further increases the weight of, dysfunction of liver, fat metabolic disturbance, hepatic tissue official fat-like and the sex change of cavity sample, finally cause liver cell extensive necrosis, and cellular swelling is dead.Therefore, remove free radical inhibition peroxidatic reaction of lipid, protection liver cell, recovers liver normal function, is the key that control ALD occurs and develops.
Summary of the invention
The object of this invention is to provide a kind of composition and method of making the same alcoholic liver injury to auxiliary protection function.
The present invention also provides the purposes of described composition, is mainly used in health food or functional food.
A kind of composition alcoholic liver injury to auxiliary protection function of the present invention, comprises that the raw material of following weight portion forms:
Kudzu root extract 57.5-172.5 part, raisin tree seed extract 22.5-67.5 part, Salvia root P.E 35-105 part, Turmeric P.E 18-57 part, ammonium glycyrrhetate 7.5-22.5 part.
Wherein, preferred raw material weight umber is:
115 parts of kudzu root extracts, 45 parts of raisin tree seed extracts, 70 parts of Salvia root P.Es, 37.5 parts of Turmeric P.Es, 15 parts of ammonium glycyrrhetates.
Composition of the present invention, also contains one or more auxiliary materials in microcrystalline cellulose, PVPP, dolomol, dextrin, sucrose, or the conventional pharmaceutical adjunct in other this areas.
Composition of the present invention, prepares by the following method: kudzu root extract, raisin tree seed extract, Salvia root P.E, Turmeric P.E, ammonium glycyrrhetate are crossed respectively to 80 mesh sieves, add auxiliary material, through steps such as batching, mixing, make preparation.
Composition primary raw material effect of the present invention is as follows:
1, kudzu root extract: the root of kudzu vine is sweet, pungent, cool.Return spleen, stomach, lung channel.Relieving muscles to expel heat, promotes the production of body fluid to quench thirst, and promoting eruption rises positive antidiarrheal, clearing and activating the channels and collaterals, relieving alcoholism.For fever caused by exogenous pathogens headache, stiff nape and back, thirsty, quench one's thirst, measles without adequate eruption, hot dysentery, has loose bowels, dizziness and headache, hemiplegia, chest impediment and cardialgia, in wine poison wound.The root of kudzu vine is the traditional Sobering-up Chinese medicine of China, and its main component is flavone compound, containing daidzin, Daidzein and Puerarin, has the effect of protection liver cell 26S Proteasome Structure and Function integrality, and alcoholic liver injury is had to certain therapeutic action.Feng Qin etc. study discovery, root of kudzu vine water extraction liquid can significantly reduce alcoholic liver injury rat model serum alt, AST content, significantly improve SOD content and reduction MDA content in liver organization, suppressing lipid peroxidation injury may be one of effect link of root of kudzu vine resisting alcoholic hepatic injury.The root of kudzu vine is loose can be improved alcoholic liver injury Mouse Liver microsome Cytochrome P450 (CYP450) content and reduce Cytochrome P450-2E1 (CYP2E1) activity, and acute alcohol liver damage Mouse Liver function is had to optimum intervention effect.Puerarin has the effect that reduces acute alcoholism SD rat Ethanol concentration in rat blood, and alcoholic liver injury is had to protective effect, alleviates the murder by poisoning of ethanol to health.Root of kudzu vine Radix Glycyrrhizae compound formulation can obviously reduce TG content in alcoholic hepatic injury liver tissues of rats, rising GSH content, and can improve hepatic cell fattydegeneration, alcoholic liver injury is had to prevention effect.
2, raisin tree seed extract: hoveniae semoveniae semen is the mature seed of northern trifoliate orange Dulcis, trifoliate orange Dulcis, comospore trifoliate orange Dulcis.Main component is saponin(e, alkaloid and flavones ingredient.The traditional Chinese medical science thinks that hoveniae semoveniae semen has reducing fever and causing diuresis, and the effect of relieving alcoholism cures mainly the diseases such as wine disease, dysphoria with smothery sensation, thirsty, vomiting, difficulty in urination and defecation.Pharmacological research shows, northern trifoliate orange Dulcis can extend the drunk time and shorten because of the drunk length of one's sleep of causing, and alcohol metabolism in acceleration bodies suppresses of flaccid muscles due to ethanol, important enzyme in activation alcohol metabolism process.Hoveniae semoveniae semen methanolic extract can improve acute hepatic injury mice GSH anti-oxidation function, strengthen the GSH association reaction of GST catalysis, increase SOD, CAT active, the acute liver due to antagonism ethanol.Hoveniae semoveniae semen aqueous extract in advance gastric infusion can stop the mouse liver MDA due to ethanol to raise and GSH decline; and cholesterol, triglycerides due to energy Anti-ethanol increase; point out it to alcohol, to cause mouse liver lipid peroxidation and there is protective effect, and likely delay and prevent the formation of the fatty liver due to ethanol.Hoveniae semoveniae semen general flavone can significantly reduce ALT in rat blood serum, AST, TNF-α, HA, LN content, reduce hepatic tissue and produce MDA, rising IL-10 level, alleviates the inflammatory reaction that alcohol causes, and formation that may be to anti-hepatic fibrosis, the hepatic injury that alcohol is caused has good preventive and therapeutic effect.
3, Salvia root P.E: the red sage root, hardship, is slightly cold.The thoughts of returning home, Liver Channel.There is promoting blood circulation, inducing meastruation to relieve menalgia, the relieving restlessness that clears away heart-fire, the cool blood carbuncle that disappears, for chest impediment and cardialgia, gastral cavity abdominal rib Tong , lumps in the chest and abdomen, hot numbness pain, dysphoria and insomnia, irregular menstruation, dysmenorrhoea is through closing, and sore swells and ache.Effective component in red sage mostly is fat-soluble tanshinone and water miscible danshinolic acid class.Motherland's medical science thinks, it is long-pending that the alcohol impariment of the liver mostly is the wine poison stasis of blood, due to damp and hot stifling liver, all has the factor of the stasis of blood from the cause of disease, pathological analysis.The pharmacological action of the red sage root is promoting blood circulation and removing blood stasis just, and modern pharmacology is thought and improved microcirculation by the expansible blood vessel of the red sage root, suppresses blood coagulation, increases internal organs CBF and reduces the effects such as blood viscosity.The red sage root also has antioxidation, by improving the activity of superoxide dismutase in blood, and oxygen radical in scavenger-cell, anti-oxidative defense ability in reinforcement, to improve cell membrane stability, thus Cell protection.The red sage root truly has protective effect to acute alcohol liver damage.
Studies show that Tanshinone II
acan reduce hepatic injury mice serum ALT, AST, reduce the content of hepatic tissue MDA, remove oxygen radical, performance antioxidation activity, there is obvious liver protection.The red sage root can alleviate hepatic cell fattydegeneration, the necrosis that alcohol causes, lowers hepatic tissue toll sample acceptor 4 (TLR4) mrna expressions and heme oxygenase-1 (HO-1) mrna expression, and can make TLR4 positive cell number obviously reduce.The red sage root can be by reducing the caused hepatic injury of alcohol on the impact of TLR4 signal transduction path.
4, Turmeric P.E: turmeric, acrid, bitter, warm.Return spleen, Liver Channel.Broken blood gas, inducing meastruation to relieve menalgia.For the shouting pain of the chest side of body, chest impediment and cardialgia, dysmenorrhoea is through Bi , Disorder lump in the abdomen, and rheumatism is takeed on arm pain, tumbling and swelling.Curcumin is its main chemical compositions.Modern pharmacological research shows, the mechanism of action of curcumin anti-liver injury is mainly manifested in and removes liver free radical, suppresses inflammation reaction and suppress the several respects such as Hepatic Stellate Cell Activation.Curcumin can reduce MDA content in liver injury model animal blood serum ALT, AST, NO content and hepatic tissue, has obvious hepatoprotective effect.Curcumin can pass through to suppress the expression of NF-κ B in alcoholism lipid peroxidation in rats and hepatic tissue, thereby alleviates or prevent and treat the hepatic injury of alcohol induction.Curcumin can alleviate the liver fat sex change of alcohol induction, suppress the release of serum transaminase, improve disorders of lipid metabolism, and suppresses the oxidative damage of accumulating, slow down hepatic tissue of ROS in liver, thereby the hepatic injury of alcohol induction is shielded.
5, ammonium glycyrrhetate: glycyrrhizic acid is the active ingredient of glycyrrhiza uralensis fisch, has anti-inflammatory, antiallergy and liver-protective effect.Radix Glycyrrhizae acids medicine is clinical conventional hepatic.Ammonium glycyrrhetate is ammonium glycyrrhizinate salt material.Modern pharmacological research shows, various Radix Glycyrrhizae acids mechanisms of drug action are basically identical, and the enoxolone generating through glycuronidase effect in vivo has protection liver plasma membrane, anti-inflammatory, adjusting immunity, regulates the effects such as cytochrome P 450 Enzyme, removing toxic substances.Glycyrrhizic acid can suppress alcohol metabolism product, alleviates the immunological liver injury due to alcohol metabolism thing.Glycyrrhizic acid can be removed by raising the activity of free radical enzyme; the damage of the peroxidatic reaction of lipid of inhibition free radical mediated to liver, Cell protection film, alleviates degeneration of liver cells necrosis and alleviates; thereby accelerate the recovery of cell function, alcoholic liver injury is played a protective role.
Composition of the present invention is made following oral formulations: capsule, tablet, granule or oral liquid, be preferably capsule or tablet.
The present invention also provides the preparation method of above-mentioned composition, and the above-mentioned method of making various oral formulations adopts this area common method, and for example the preparation method of present composition capsule, comprises the steps:
(1) supplementary material in formula is all crossed 80 mesh sieves, standby.Industrial water is purified water, should meet 2010 editions purified water requirements of < < Chinese pharmacopoeia > >; Producing ethanol used is food grade ethanol, should meet the requirement of GB 10343-2008 edible alcohol.
(2) by formula inventory, accurately take kudzu root extract, raisin tree seed extract, Salvia root P.E, Turmeric P.E, ammonium glycyrrhetate, microcrystalline cellulose; put in mixer and mix, then add ethanolic solution to make in right amount softwood, with oscillating granulator, granulate; sieve.
(3) wet granular is laid in stainless steel disc uniformly, puts forced air drying at 60 ℃ ± 3 ℃ in air dry oven, pellet moisture should be controlled in 6%.Dried particle is sieved to whole, standby.
(4) by formula inventory, accurately take dolomol, first and dried particle equivalent increases progressively mixes after three times, and whole materials are added to total mixed 30min in total mixing device.
(5) filling on automatic capsule filling machine.Populated capsule is carried out on capsule polisher to polishing.
(6) packing, check obtain standard compliant product.
The present invention also provides described composition in the application for the preparation of alcoholic liver injury being had to health food or the functional food of auxiliary protection function.
The present invention also provides described composition preparing the health food of sub-health state or the application in functional food.
In addition, the present invention also provides the functional food that contains above-mentioned composition.
The invention has the advantages that: select the raw material with the effect of auxiliary protection alcoholic liver injury; formula Design is scientific and reasonable; preparation process simple possible; quality controllable; safe; than the single kudzu root extract preparation under same dose and single raisin tree seed extract preparation, there is the more excellent effect that improves alcoholic liver injury symptom, be suitable for vast alcoholic liver injury crowd's use.
The specific embodiment
By the following specific examples further illustrate the invention, and the embodiment wherein exemplifying is only to explanation of the present invention, and can not limit the scope of the invention by any way.In following examples, kudzu root extract (Puerarin>=10%), raisin tree seed extract (10:1), Turmeric P.E (10:1) is all purchased from Yuan Sen bio tech ltd, Xi'an; Salvia root P.E (Tanshinone I I
a>=3%), purchased from San Jiang bio tech ltd, Xi'an; Ammonium glycyrrhetate (>=75%), purchased from Shaanxi Fu Jie pharmaceutcal corporation, Ltd.
Embodiment 1
Formula: kudzu root extract 115g, raisin tree seed extract 45g, Salvia root P.E 70g, Turmeric P.E 37.5g, ammonium glycyrrhetate 15g, microcrystalline cellulose 56g, dolomol (additional) 1.5g.
Preparation method:
1, the supplementary material in formula is all crossed 80 mesh sieves, standby.Industrial water is purified water, should meet 2010 editions purified water requirements of < < Chinese pharmacopoeia > >; Producing ethanol used is food grade ethanol, should meet the requirement of GB 10343-2008 edible alcohol.
2, by formula inventory, accurately take kudzu root extract, raisin tree seed extract, Salvia root P.E, Turmeric P.E, ammonium glycyrrhetate, microcrystalline cellulose; put in mixer and mix, then add ethanolic solution to make in right amount softwood, with oscillating granulator, granulate; sieve.
3, wet granular is laid in stainless steel disc uniformly, puts forced air drying at 60 ℃ ± 3 ℃ in air dry oven, pellet moisture should be controlled in 6%.Dried particle is sieved to whole, standby.
4, by formula inventory, accurately take dolomol, first and dried particle equivalent increases progressively mixes after three times, and whole materials are added to total mixed 30min in total mixing device.
5, filling on automatic capsule filling machine.Populated capsule is carried out on capsule polisher to polishing.
6, packing, check obtain standard compliant product.
Embodiment 2:
Formula: kudzu root extract 172.5g, raisin tree seed extract 22.5g, Salvia root P.E 62g, Turmeric P.E 18g, ammonium glycyrrhetate 7.5g, microcrystalline cellulose 185g, PVPP 30g, dolomol 2.5g, film coating pre-mix dose 15g.
Preparation method: supplementary material mixes, sieves, and compressing tablet is made tablet, and package test obtains meeting standardized product.
Embodiment 3:
Formula: kudzu root extract 57.5g, raisin tree seed extract 67.5g, Salvia root P.E 105g, Turmeric P.E 30g, ammonium glycyrrhetate 22.5g, dextrin 217.5g.
Preparation method: supplementary material mixes, sieves, granulates, and granulation agent, package test obtains meeting standardized product.
Embodiment 4:
Formula: kudzu root extract 125g, raisin tree seed extract 55g, Salvia root P.E 35g, Turmeric P.E 57g, ammonium glycyrrhetate 10.5g, sucrose 90g.
Preparation method: supplementary material mixes, adds water and dissolves in right amount, filters, and makes oral liquid.Package test obtains standard compliant product.
By toxicological test and function test, further set forth the present invention below, due to capsule involved in the present invention, tablet, granule, oral liquid, except formulation, auxiliary material difference, primary raw material, every day, amount, functional component were all identical, do not affect safety and the function of product, therefore select the product of embodiment 1 preparation to carry out toxicity and function test, no longer other formulations repeated.
Test example 1 toxicological test
The above embodiment of the present invention product promulgates that according to the Ministry of Public Health check of < < health food and assessment technique standard > > (version in 2003) related request carry out toxicology test, and concrete test method is shown in above-mentioned standard.
Toxicological experiment proves, the maximum tolerated dose of Kunming mouse acute oral is greater than 15.0g/kgbw, belongs to nontoxic level; Three genetic toxicity tests (Salmonella reversion test, PCEMNR micronucleus test, mouse sperm deformity test), result is all negative.With the Capsule content of 2.3g/kgbw, 3.4g/kgbw, 4.5g/kgbw (be equivalent to respectively human body RD 50,75,100 times) to rat oral gavage 30 days, duration of test, each treated animal grows well, each dosage of sample is to rat body weight, body weight gain, average food-intake and food utilization and the comparison of solvent control group, without significant difference (P>0.05).Each dosage group hematological indices, blood biochemistry index, dirty body ratio and the comparison of solvent control group, there was no significant difference (P>0.05).Solvent control group has no the abnormal change relevant with sample with high dose group gross anatomy and histopathological examination.
Test example 2 function tests
Test objective: whether check product has auxiliary protection function to alcoholic liver injury to animal
The capsule that test material: embodiment 1 makes
Dosage arranges and selects: dosage group (primary raw material content is 0.38g/kgbw), present composition high dose group (primary raw material content is 0.76g/kgbw), kudzu root extract group (kudzu root extract content is 0.76g/kgbw), raisin tree seed extract group (raisin tree seed extract content is 0.76g/kgbw) in blank group, model control group, present composition low dose group (primary raw material content is 0.19g/kgbw), the present composition.Wherein the basic, normal, high dosage group of the present composition is equivalent to respectively 5,10,20 times of human body RD.
Test method: promulgate, in the check of < < health food and assessment technique standard > > (version in 2003), chemical damage to be had to the method for inspection of auxiliary protection function according to the Ministry of Public Health.
Result of the test:
1, the impact of given the test agent on Mouse Weight
Each given the test agent is through mouse stomach 30d, there are no significant difference (P>0.05) that blank group, model control group, kudzu root extract group, raisin tree seed extract group, the basic, normal, high dosage group of the present composition group mesosome method of double differences be different, the results are shown in Table 1.
Table 1 given the test agent on the impact of Mouse Weight (n=10,
)
2, the impact of given the test agent on mouse liver biochemical indicator
In model control group liver, MDA, TG content are all significantly higher than blank group (P<0.01 or P<0.05), GSH activity is significantly lower than blank group (P<0.05), and experiment modeling is successful.With model control group comparison, kudzu root extract group and raisin tree seed extract group all significantly reduce MDA content (P<0.05) in alcoholic liver injury animal's liver, GSH active (P<0.05) in its liver that significantly raises; Present composition low dose group can significantly reduce MDA content (P<0.05) in alcoholic liver injury animal's liver, GSH active (P<0.05) in its liver that significantly raises; The middle and high dosage group of the present composition can significantly reduce MDA in alcoholic liver injury animal's liver, TG content (P<0.05 or P<0.01), GSH active (P<0.05 or P<0.01) in its liver that significantly raises; In present composition high dose group animal's liver, MDA, TG content are significantly lower than kudzu root extract group and raisin tree seed extract group (P<0.05), and GSH activity is significantly higher than kudzu root extract group and raisin tree seed extract group (P<0.05).Present composition group is better than single kudzu root extract preparation and the single raisin tree seed extract preparation under same dose to the protective effect of alcoholic liver injury animal's liver.The results are shown in Table 2.
Table 2 given the test agent on the impact of mouse liver biochemical indicator (n=10,
)
Note: with model control group comparison, * P<0.05, * * P<0.01; With the comparison of present composition high dose group, #P<0.05, ##P<0.01
3, histopathologic examination's result
The degree that model control group liver fat changes is significantly higher than blank group (P<0.01); With model control group comparison, kudzu root extract group, the basic, normal, high dosage group of the present composition can significantly be improved the liver fat denaturation degrees (P<0.05 or P<0.01) of alcoholic liver injury animal; Present composition high dose group is significantly higher than kudzu root extract group and raisin tree seed extract group (P<0.05) to the improvement degree of alcoholic liver injury animal's liver steatosis, illustrates that to a certain extent present composition group is better than single kudzu root extract preparation and the single raisin tree seed extract preparation under same dose to the protective effect of alcoholic liver injury.The results are shown in Table 3.
Table 3 given the test agent on the impact of mouse liver fatty change degree (n=10,
)
Note: with model control group comparison, * P<0.05, * * P<0.01; With the comparison of present composition high dose group, #P<0.05, ##P<0.01
Conclusion: according to above-mentioned result of the test, according to the Ministry of Public Health, promulgate the middle result judgement of the check of < < health food and value disciplines > > (version in 2003), meet arbitrary condition, can judge that given the test agent has alcoholic liver injury is had to auxiliary protection function: it is positive that liver MDA, reduced form GSH and tri-of TG detect index results; In liver MDA, reduced form GSH and tri-indexs of TG, wantonly two index positives and histopathologic examination's result are positive.The present composition is described, kudzu root extract has that alcoholic liver injury is had to auxiliary protection function.Animal experiment proves, the present composition is better than single kudzu root extract preparation and the single raisin tree seed extract preparation under same dose to alcoholic liver injury auxiliary protection function.
The above is only the preferred embodiment of the present invention, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to above-mentioned example.It should be pointed out that according to foregoing of the present invention, according to ordinary skill knowledge and the customary means of this area, not departing under the above-mentioned basic fundamental thought of the present invention prerequisite, to content of the present invention, can also make modification, replacement or the change of various ways.All technology realizing based on foregoing of the present invention all belong to scope of the present invention.
Claims (10)
1. alcoholic liver injury is there is to a composition for auxiliary protection function, it is characterized in that: mainly take kudzu root extract, raisin tree seed extract, Salvia root P.E, Turmeric P.E, ammonium glycyrrhetate makes oral formulations as raw material; The parts by weight that wherein comprise raw material are: kudzu root extract 57.5-172.5 part, raisin tree seed extract 22.5-67.5 part, Salvia root P.E 35-105 part, Turmeric P.E 18-57 part, ammonium glycyrrhetate 7.5-22.5 part.
2. composition alcoholic liver injury to auxiliary protection function according to claim 1, is characterized in that, mainly adopts the raw material of following weight portion to make:
115 parts of kudzu root extracts, 45 parts of raisin tree seed extracts, 70 parts of Salvia root P.Es, 37.5 parts of Turmeric P.Es, 15 parts of ammonium glycyrrhetates.
3. composition according to claim 1 and 2, is characterized in that, also contains one or more auxiliary materials in microcrystalline cellulose, PVPP, dolomol, dextrin, sucrose, or the conventional pharmaceutical adjunct in other this areas.
4. according to the composition described in claim 1-3 any one, it is characterized in that, described composition is prepared by the following method: kudzu root extract, raisin tree seed extract, Salvia root P.E, Turmeric P.E, ammonium glycyrrhetate are crossed respectively 80 mesh sieves, add auxiliary material, through steps such as batching, mixing, make preparation.
5. according to the composition described in claim 1-3 any one, it is characterized in that described oral formulations is that medically acceptable various formulations comprise capsule, tablet, granule or oral liquid.
6. composition according to claim 5, preferred oral formulations is capsule or tablet.
7. the method for preparing composition described in claim 1-6 any one, is characterized in that, it comprises the steps:
(1), kudzu root extract, raisin tree seed extract, Salvia root P.E, Turmeric P.E, ammonium glycyrrhetate respectively to 80 mesh sieves excessively, standby;
(2), by the kudzu root extract after sieving, raisin tree seed extract, Salvia root P.E, Turmeric P.E, ammonium glycyrrhetate, put in mixer and mix, then add auxiliary material, make oral formulations.
According to the composition described in claim 1-6 any one in the health food for the preparation of auxiliary protection alcoholic liver injury or the application in functional food.
9. according to the composition described in claim 1-6 any one, in preparation, improve the health food of inferior health or the application in functional food.
10. the functional food that contains composition described in claim 1-6 any one.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410356846.9A CN104172159A (en) | 2014-07-24 | 2014-07-24 | Composition with auxiliary protection effect on alcoholic liver injury and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410356846.9A CN104172159A (en) | 2014-07-24 | 2014-07-24 | Composition with auxiliary protection effect on alcoholic liver injury and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104172159A true CN104172159A (en) | 2014-12-03 |
Family
ID=51953725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410356846.9A Pending CN104172159A (en) | 2014-07-24 | 2014-07-24 | Composition with auxiliary protection effect on alcoholic liver injury and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104172159A (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104605058A (en) * | 2015-01-01 | 2015-05-13 | 张志科 | Composition, tea cream and application |
CN104667196A (en) * | 2015-03-26 | 2015-06-03 | 江苏康缘药业股份有限公司 | Composition with protection effect against liver with chemical injuries, preparation method and traditional Chinese medicine preparation |
CN105410569A (en) * | 2015-12-08 | 2016-03-23 | 广东省农业科学院蚕业与农产品加工研究所 | Preparation method of mulberry drink with protective effect on alcoholic liver injury |
CN105816798A (en) * | 2016-04-13 | 2016-08-03 | 南昌济顺制药有限公司 | Liver protecting drug or health food composition |
CN105999212A (en) * | 2016-05-13 | 2016-10-12 | 无限极(中国)有限公司 | Composition having alcohol effect dispelling effect and preparation method and application thereof |
CN106135891A (en) * | 2015-04-15 | 2016-11-23 | 吉林省中医药科学院 | A kind of health food to alcoholic liver injury with defencive function |
CN108652000A (en) * | 2018-03-07 | 2018-10-16 | 姜学林 | Imperial bud liver-protecting and alcoholism-relieving solid articles of a kind of compound thorn and preparation method thereof |
CN109965072A (en) * | 2019-04-08 | 2019-07-05 | 杭州花姐食品有限公司 | A kind of pressed candy and the preparation method and application thereof conserving liver |
CN111887332A (en) * | 2020-08-05 | 2020-11-06 | 重庆西大魔芋生物科技有限公司 | Konjak chocolate capable of dispelling effects of alcohol, protecting liver and benefiting intestines and preparation method thereof |
CN112535230A (en) * | 2020-11-12 | 2021-03-23 | 浙江英格莱制药有限公司 | Herbaceous plant corn peptide vitamin sugar pill and preparation method thereof |
CN113694104A (en) * | 2021-07-23 | 2021-11-26 | 江苏大学 | Traditional Chinese medicine composition with protection effect on chemical liver injury and liver regeneration promotion function, preparation method and application thereof |
CN114949139A (en) * | 2022-05-17 | 2022-08-30 | 健码制药(广东)有限公司 | Composition for relieving alcoholic liver injury and preparation process thereof |
CN115337376A (en) * | 2022-08-24 | 2022-11-15 | 辽宁泰阳医药科技开发有限公司 | Traditional Chinese medicine composition with liver protecting and toxin expelling effects, preparation method and application thereof |
CN115487280A (en) * | 2022-10-19 | 2022-12-20 | 浙江中医药大学 | Traditional Chinese medicine composition for relieving alcoholism, protecting liver and promoting liver regeneration, preparation and preparation method thereof |
CN115886254A (en) * | 2022-10-08 | 2023-04-04 | 睿丽生命科技(江苏)有限公司 | Food for dispelling effects of alcohol and protecting liver |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1883687A (en) * | 2006-05-31 | 2006-12-27 | 北京药谷传奇医药科技开发有限公司 | Liver-benefiting health food made from pure Chinese medicine |
CN102188513A (en) * | 2011-05-25 | 2011-09-21 | 遵义陆圣康源科技开发有限责任公司 | Medical composition with auxiliary protection function for chemical liver damage |
CN102342357A (en) * | 2010-07-27 | 2012-02-08 | 襄樊隆中药业有限责任公司 | Formula of antialcoholismic heterosugar tablet and its preparation method |
CN102450714A (en) * | 2010-10-22 | 2012-05-16 | 赵强 | Alcoholism-relieving drink and preparation method thereof |
CN102670763A (en) * | 2012-06-01 | 2012-09-19 | 广州市奥海生物科技有限公司 | Composition with auxiliary protection effect on chemical liver injury and preparation method of composition |
CN102671093A (en) * | 2012-01-04 | 2012-09-19 | 河南科技大学 | Sober-up tea and preparation thereof |
-
2014
- 2014-07-24 CN CN201410356846.9A patent/CN104172159A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1883687A (en) * | 2006-05-31 | 2006-12-27 | 北京药谷传奇医药科技开发有限公司 | Liver-benefiting health food made from pure Chinese medicine |
CN102342357A (en) * | 2010-07-27 | 2012-02-08 | 襄樊隆中药业有限责任公司 | Formula of antialcoholismic heterosugar tablet and its preparation method |
CN102450714A (en) * | 2010-10-22 | 2012-05-16 | 赵强 | Alcoholism-relieving drink and preparation method thereof |
CN102188513A (en) * | 2011-05-25 | 2011-09-21 | 遵义陆圣康源科技开发有限责任公司 | Medical composition with auxiliary protection function for chemical liver damage |
CN102671093A (en) * | 2012-01-04 | 2012-09-19 | 河南科技大学 | Sober-up tea and preparation thereof |
CN102670763A (en) * | 2012-06-01 | 2012-09-19 | 广州市奥海生物科技有限公司 | Composition with auxiliary protection effect on chemical liver injury and preparation method of composition |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104605058A (en) * | 2015-01-01 | 2015-05-13 | 张志科 | Composition, tea cream and application |
CN104667196A (en) * | 2015-03-26 | 2015-06-03 | 江苏康缘药业股份有限公司 | Composition with protection effect against liver with chemical injuries, preparation method and traditional Chinese medicine preparation |
CN106135891A (en) * | 2015-04-15 | 2016-11-23 | 吉林省中医药科学院 | A kind of health food to alcoholic liver injury with defencive function |
CN105410569A (en) * | 2015-12-08 | 2016-03-23 | 广东省农业科学院蚕业与农产品加工研究所 | Preparation method of mulberry drink with protective effect on alcoholic liver injury |
CN105410569B (en) * | 2015-12-08 | 2018-07-24 | 广东省农业科学院蚕业与农产品加工研究所 | A kind of preparation method to mulberry beverage of the alcoholic liver injury with protective effect |
CN105816798A (en) * | 2016-04-13 | 2016-08-03 | 南昌济顺制药有限公司 | Liver protecting drug or health food composition |
CN105999212A (en) * | 2016-05-13 | 2016-10-12 | 无限极(中国)有限公司 | Composition having alcohol effect dispelling effect and preparation method and application thereof |
CN108652000A (en) * | 2018-03-07 | 2018-10-16 | 姜学林 | Imperial bud liver-protecting and alcoholism-relieving solid articles of a kind of compound thorn and preparation method thereof |
CN109965072A (en) * | 2019-04-08 | 2019-07-05 | 杭州花姐食品有限公司 | A kind of pressed candy and the preparation method and application thereof conserving liver |
CN111887332A (en) * | 2020-08-05 | 2020-11-06 | 重庆西大魔芋生物科技有限公司 | Konjak chocolate capable of dispelling effects of alcohol, protecting liver and benefiting intestines and preparation method thereof |
CN112535230A (en) * | 2020-11-12 | 2021-03-23 | 浙江英格莱制药有限公司 | Herbaceous plant corn peptide vitamin sugar pill and preparation method thereof |
CN113694104A (en) * | 2021-07-23 | 2021-11-26 | 江苏大学 | Traditional Chinese medicine composition with protection effect on chemical liver injury and liver regeneration promotion function, preparation method and application thereof |
CN114949139A (en) * | 2022-05-17 | 2022-08-30 | 健码制药(广东)有限公司 | Composition for relieving alcoholic liver injury and preparation process thereof |
CN114949139B (en) * | 2022-05-17 | 2023-02-03 | 健码制药(广东)有限公司 | Composition for relieving alcoholic liver injury and preparation process thereof |
CN115337376A (en) * | 2022-08-24 | 2022-11-15 | 辽宁泰阳医药科技开发有限公司 | Traditional Chinese medicine composition with liver protecting and toxin expelling effects, preparation method and application thereof |
CN115886254A (en) * | 2022-10-08 | 2023-04-04 | 睿丽生命科技(江苏)有限公司 | Food for dispelling effects of alcohol and protecting liver |
CN115487280A (en) * | 2022-10-19 | 2022-12-20 | 浙江中医药大学 | Traditional Chinese medicine composition for relieving alcoholism, protecting liver and promoting liver regeneration, preparation and preparation method thereof |
CN115487280B (en) * | 2022-10-19 | 2023-12-19 | 浙江中医药大学 | Traditional Chinese medicine composition for dispelling effects of alcohol, protecting liver and promoting liver regeneration as well as preparation and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104172159A (en) | Composition with auxiliary protection effect on alcoholic liver injury and preparation method thereof | |
CN102895478B (en) | Kidney-warming yang-supporting medicine composition and preparation method thereof | |
CN110833595B (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
Zhan et al. | Chemical constituents and pharmacological effects of durian shells in ASEAN countries: A review | |
CN106177183A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori | |
WO2016202183A1 (en) | Formula dog food and preparation method therefor | |
CN103006822A (en) | Application of American ginseng in preparing medicament for preventing and treating alcoholic liver injury | |
CN109432194B (en) | A Chinese medicinal composition for treating hemorrhoid, and its preparation method | |
CN105267906A (en) | Compound chocolate Chinese herbal composition for treating and improving menstrual syndrome of females | |
CN105770579A (en) | Medicinal and edible homologous traditional Chinese medicine composition with liver-protecting effect | |
CN104435977B (en) | It is a kind of to be used to treat medicine of hepatic injury and preparation method thereof | |
CN103751547B (en) | Chinese medicine composition of a kind of blood fat reducing and preparation method thereof | |
CN102805844A (en) | Medicine for treating liver cancer | |
CN105833075A (en) | Traditional Chinese medicine preparation for preventing rabbit haemorrhagic diseases | |
CN105362785A (en) | Medicine composition for treating primary hypertension and preparation method thereof | |
CN102343050A (en) | Eye ointment for treating eye diseases | |
CN103623109B (en) | Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof | |
CN106390035A (en) | Traditional Chinese medicine preparation for treating mammary gland hyperplasia | |
CN108210651B (en) | A natural medicinal composition for treating diabetic nephropathy, and its preparation method | |
CN105169278A (en) | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
CN103735906A (en) | Chinese herb preparation for treating dry bronchiectasis and preparation method thereof | |
CN103861041A (en) | Traditional Chinese medicinal composition for treating acute and chronic rhinitis and preparation method thereof | |
CN104887866A (en) | Traditional Chinese medicine for treating gout | |
CN105168844A (en) | Medicine for treating portal hypertension postoperative treating thrombosis | |
CN104606638A (en) | Medicine for treating damp-heat type acute eczema and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141203 |